Fractional Laser as Treatment Option for Various Pigment Disorders (Fractional-3)

Pigmentation Disorder Clinical Trial

Official title:
Non-ablative 1,550 nm Fractional Laser Therapy Versus Triple Topical Therapy for the Treatment of Melasma: a Randomized Controlled Split-face Study

Status Completed

Clinical Trial Summary

The purpose of this study is to determine whether the use of non-ablative fractional laser is safe and effective in the treatment of melasma.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01085279
Study type	Interventional
Source	Netherlands Institute for Pigment Disorders
Contact
Status	Completed
Phase	Phase 2
Start date	March 2009
Completion date	February 2010

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05913102` - A Prospective, Split-face, Randomized Study of the Poly-D, L Lactic Acid (PDLLA) for Photoaged Skin	N/A
Active, not recruiting	`NCT04971200` - Pilot Study Assessing the Effect of Tildrakizumab in Vitiligo	Early Phase 1
Completed	`NCT01083498` - Fractional Laser as Treatment Option for Various Pigment Disorders	Phase 2
Recruiting	`NCT06122090` - Treatment of Hypopigmented Scars With Bimatoprost	Phase 2
Completed	`NCT05710068` - Effects of RF Microneedle on Photoaging Skin	N/A